Early HIV infection: to treat or not to treat?
作者信息
Swart A M, Weller I, Darbyshire J H
出版信息
BMJ. 1990 Oct 13;301(6756):825-6. doi: 10.1136/bmj.301.6756.825.
Abstract
摘要
相似文献
1
Early HIV infection: to treat or not to treat?
BMJ. 1990 Oct 13;301(6756):825-6. doi: 10.1136/bmj.301.6756.825.
2
[Treatment of HIV infection with zidovudine. The good use of AZT].
Rev Prat. 1991 Sep 1;41(19):1801-4.
3
Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
J Infect. 1989 Jan;18 Suppl 1:77. doi: 10.1016/s0163-4453(89)80083-0.
4
Zidovudine--the first year of experience.
J Infect. 1989 Jan;18 Suppl 1:23-31. doi: 10.1016/s0163-4453(89)80077-5.
5
Zidovudine in asymptomatic HIV infection: knowledge and uncertainty.
Int J STD AIDS. 1991 May-Jun;2(3):157-61. doi: 10.1177/095646249100200301.
6
[Long-term success with zidovudine in HIV infection].
Leber Magen Darm. 1989 May;19(3):158.
7
[Zidovudine (AZT). Current state of the development].
Ann Med Interne (Paris). 1991;142(6):444-55.
8
Clinical trials of zidovudine in HIV infection.
Lancet. 1989 Aug 26;2(8661):483-4.
9
Half-dose zidovudine.
Lancet. 1991 May 4;337(8749):1109. doi: 10.1016/0140-6736(91)91766-n.
10
Treatment of children symptomatic with human immunodeficiency virus infection.
J Infect. 1989 Jan;18 Suppl 1:81-2. doi: 10.1016/s0163-4453(89)80085-4.
引用本文的文献
1
Will we ever know when to treat HIV infection?
BMJ. 1996 Sep 7;313(7057):608-10. doi: 10.1136/bmj.313.7057.608.
2
Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.
Thorax. 1993 May;48(5):481-5. doi: 10.1136/thx.48.5.481.
3
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.
BMJ. 1991 Jan 26;302(6770):203-7. doi: 10.1136/bmj.302.6770.203.
4
Early HIV infection.
BMJ. 1990 Oct 27;301(6758):987. doi: 10.1136/bmj.301.6758.987-a.
5
Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
BMJ. 1991 Nov 2;303(6810):1093-6. doi: 10.1136/bmj.303.6810.1093.
6
Infectious diseases and AIDS.
Postgrad Med J. 1992 Jun;68(800):415-33. doi: 10.1136/pgmj.68.800.415.
7
Disseminated cytomegalovirus infection.
Genitourin Med. 1992 Apr;68(2):75-9. doi: 10.1136/sti.68.2.75.
本文引用的文献
1
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
JAMA. 1989 Nov 3;262(17):2405-10.
2
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
Science. 1989 Mar 31;243(4899):1731-4. doi: 10.1126/science.2467383.
3
Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection.
Genitourin Med. 1990 Jun;66(3):133-7. doi: 10.1136/sti.66.3.133.
4
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
5
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
N Engl J Med. 1990 Apr 5;322(14):941-9. doi: 10.1056/NEJM199004053221401.
Zotero 插件